31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
On June 3, 2019, the U.S. District Court for the Southern District of New York granted a defendant-e...
Read More >
Effective February 11, 2020, the 10 members with the largest percentage ownership in an out-of-state...
Read More >
Welcome to the Science of Star Trek, a podcast series inspired by my review of Star Trek, the Origin...
Read More >
The EU Justice and Home Affairs Council has formally adopted a Directive of the EU Parliament, which...
Read More >
Earlier this week, the NLRB made official a less stringent standard on joint employer liability, ret...
Read More >
The California Supreme Court has handed down yet another decision broadening the scope of what is co...
Read More >